NEW YORK ( TheStreet) -- Omnicell (Nasdaq: OMCL) hit a new 52-week high Thursday as it is currently trading at $16.63, above its previous 52-week high of $16.53 with 7,496 shares traded as of 10:02 a.m. ET. Average volume has been 159,400 shares over the past 30 days.

Omnicell has a market cap of $539.2 million and is part of the technology sector and computer hardware industry. Shares are up 13.1% year to date as of the close of trading on Wednesday.

Omnicell, Inc. develops, markets, sells, and supports medication and supply dispensing systems to the healthcare industry primarily in the United States and Canada. The company has a P/E ratio of 116.3, equal to the average computer hardware industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
  • Practice your OMCL trading strategies and win cash in our stock game.

TheStreet Ratings rates Omnicell as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and weak operating cash flow. You can view the full Omnicell Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Insider Trading Alert - XPLR, ACET And OMCL Traded By Insiders

These Small-Cap Growth Stocks Look Ready to Pop

Insider Trading Alert - SON, GES And OMCL Traded By Insiders

RBC Capital Markets Likes These 13 Small-Cap Stocks for Your 2016 Portfolio

Insider Trading Alert - CVGW, OMCL And LLY Traded By Insiders